ISS/SIC
Journal (WJS)
Congress
Create Account
Login
International Society of Surgery (ISS)
Société Internationale de Chirurgie (SIC)
Integrated Societies: IATSIC | IASMEN | BSI | ISDS
SURGICAL OUTCOMES OF NON-BENCHMARK PERIHILAR CHOLANGIOCARCINOMA: A MULTICENTER STUDY FROM HIGH-VOLUME CENTERS IN JAPAN
t.sugiura@scchr.jp
 
Back
Slot ID
Abstract Title
SURGICAL OUTCOMES OF NON-BENCHMARK PERIHILAR CHOLANGIOCARCINOMA: A MULTICENTER STUDY FROM HIGH-VOLUME CENTERS IN JAPAN
Author Details
No. of Authors
1
Including the presenting author
Author 1
Teiichi Sugiura t.sugiura@scchr.jp Shizuoka Cancer Center Division of Hepato-Biliary-Pancreatic Surgery Shizuoka Japan *
Author 2
Author 3
Author 4
Author 5
Author 6
Author 7
Author 8
Author 9
Author 10
Author 11
Author 12
Presenting Author Name
Teiichi Sugiura
Presenting Author Email
t.sugiura@scchr.jp
Presenting Author Country
Japan
Abstract
Abstract type
Oral or Poster
Introduction *
Benchmark (BM) criteria have been proposed to standardize outcomes in complex hepatopancreatobiliary surgery, but they often exclude patients with significant comorbidities or technically demanding procedures. As a result, non-benchmark (non-BM) patients with perihilar cholangiocarcinoma (PHC), who represent a majority in real-world practice, remain underrepresented in the literature.
Material & Method *
Between 2014 and 2018, a total of 648 patients underwent resection for PHC at six high volume centers in Japan. Of these, 412 patients (64 %) were categorized as non BM. Perioperative and oncologic outcomes were analyzed and compared with benchmark thresholds previously reported in the literature. Non BM cases were further stratified into surgical, medical, and dual subgroups for subgroup analysis.
Results *
The median operative time (644 minutes), blood loss (1185 mL), and postoperative hospital stay (31 days) exceeded BM thresholds. Nevertheless, most postoperative outcomes, including Grade B/C post-hepatectomy liver failure (16%), bile leakage (22.8%), and 30-day mortality (2.9%), remained within benchmark reference values. The median overall survival was 44.4 months, with 1-, 3-, and 5-year survival rates of 85.8%, 55.0%, and 35.4%, respectively. Subgroup analysis revealed decreasing survival with increasing complexity: 5-year survival rates were 50.5% in medical, 34.1% in surgical, and 15.4% in dual non-BM patients. Notably, left hepatic trisectionectomy was associated with the highest mortality (9.5%) among all
Conclusion *
Despite increased surgical complexity and patient-related risk factors, non-BM PHC patients can achieve acceptable perioperative and long-term outcomes when treated at experienced, high-volume centers. Stratification by non-BM subgroup provides meaningful prognostic insight and may help guide surgical decision-making in complex PHC cases.
File Upload #1
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
File Upload #2
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
Select Main Category
2 Digestive Surgery organized by ISDS
Select Sub Category
2.02 Hepato-Pancreatico-Biliary Surgery
Submission Status
Withdrawn
Word counter
250
Abstract Prizes
Eligible for the BSI Free Paper Prize
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
Eligible for the Grassi Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Eligible for the Kitajima Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Vimeo Link